Acitve substances in 1 ml suspension: Neomycin sulfate 3500 IU, Polymyxin B sulfate 6000 IU и Dexamethasone 1 mg
News from Pharma Vision
- Launch of TrioVision eye drops on key markets in South-east Europe
- Launch of TravoVis Combo (travoprost+timolol) eye drops on key markets in Western Balkans.
- Launch of full ophthalmic portfolio of PharmaVision Europe in Albania
- PharmaVision Europe ophthalmic line launch during the meeting the of the Association of Ophthalmologists in the Republic of Macedonia on 20 April 2018
- Launch of UROPROST tabl. x 60 – Patented Formula for Urinary Health